Evaluation of the Protective Efficacy of Poly I:C as an Adjuvant for H9N2 Subtype Avian Influenza Inactivated Vaccine and Its Mechanism of Action in Ducks
Authors:
Open Access
- 30 January 2017
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (1) , e0170681
Abstract
Current commercial H9 avian influenza vaccines cannot provide satisfactory protective immunity against antigenic variant influenza viruses in ducks. Poly I:C, when used as an adjuvant, improves humoral and cellular immunity in many animals but has not been tested in ducks. In this study, we investigated the protective efficacy of Poly I:C as an adjuvant for an inactivated H9N2 Avian influenza vaccine in ducks. We found that an H9N2 vaccine administered with poly I:C (H9-PIC vaccine) induced a significantly more rapid response with higher anti-influenza antibody titers than those of the vaccine alone (H9 vaccine). Moreover, virus shedding was reduced in ducks immunized with the H9-PIC vaccine after challenge with an H9 subtype antigenic variant viruses. IFN-α, IFN-γ, IL-6 and MHC-II mRNA levels were all elevated in ducks receiving the H9-PIC vaccine. In addition, lower expression level of MHC-I may be a reason for inefficient protective ability against heterologous influenza viruses in H9-PIC vaccination of ducks. In conclusion, poly I:C adjuvant enhanced both humoral and cellular immune responses in ducks induced by immunization of inactivated H9N2 vaccine.Keywords
This publication has 42 references indexed in Scilit:
- Complex Reassortment of Multiple Subtypes of Avian Influenza Viruses in Domestic Ducks at the Dongting Lake Region of ChinaJournal of Virology, 2013
- Intranasal Administration of dsRNA Analog Poly(I:C) Induces Interferon-α Receptor-Dependent Accumulation of Antigen Experienced T Cells in the AirwaysPLOS ONE, 2012
- Intranasal Treatment with Poly(I·C) Protects Aged Mice from Lethal Respiratory Virus InfectionsJournal of Virology, 2012
- Phylogeography and Evolutionary History of Reassortant H9N2 Viruses with Potential Human Health ImplicationsJournal of Virology, 2011
- Compatibility of H9N2 avian influenza surface genes and 2009 pandemic H1N1 internal genes for transmission in the ferret modelProceedings of the National Academy of Sciences, 2011
- Optimization of activation requirements of immature mouse dendritic JAWSII cells for in vivo applicationOncology Reports, 2011
- Maternal immunity against avian influenza H5N1 in chickens: limited protection and interference with vaccine efficacyAvian Pathology, 2011
- PolyI:polyC12U adjuvant-combined intranasal vaccine protects mice against highly pathogenic H5N1 influenza virus variantsVaccine, 2009
- Avian influenza vaccines and therapies for poultryComparative Immunology, Microbiology and Infectious Diseases, 2009
- Intranasal Administration of Alpha Interferon Reduces Seasonal Influenza A Virus Morbidity in FerretsJournal of Virology, 2009